The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(7 sites)

United States

Rady Children's Hospital, San Diego, California

Boston Children's Hospital, Boston, Massachusetts

Nationwide Children's Hospital, Columbus, Ohio

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

The University of Utah, Salt Lake City, Utah

Spain

Hospital Sant Joan de Déu, Barcelona

United Kingdom

Royal Manchester Children's Hospital, Manchester